Camber Energy Inc. buy melinda
Start price
16.09.21
/
50%
€78.00
Target price
16.09.22
€105.00
Performance (%)
70.51%
End price
29.09.21
€133.00
Summary
This prediction ended on 29.09.21 with a price of €133.00. With a performance of 70.51% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Camber Energy Inc. | - | - | - |
iShares Core DAX® | 2.275% | 4.627% | 18.839% |
iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% |
iShares Nikkei 225® | 4.456% | 3.598% | 12.437% |
iShares S&P 500 | 4.061% | 2.876% | 23.447% |
According to melinda what are the pros and cons of Camber Energy Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Camber Energy Inc. diskutieren
Buy mit Kursziel 2,0
Kursziel geändert auf 2,1
In the thread Trading Camber Energy Inc.
Buy beendet
Stopped prediction by melinda for Camber Energy Inc.
Camber Energy Inc.
Start price
Target price
Perf. (%)
€36.25
04.03.22
04.03.22
€50.00
04.03.23
04.03.23
-98.01%
05.03.23
05.03.23
Could be worthwhile Investment >10% per year
Camber Energy Inc.
Start price
Target price
Perf. (%)
€54.00
07.10.21
07.10.21
-
07.10.22
07.10.22
-32.87%
04.03.22
04.03.22
Could be worthwhile Investment >10% per year
Camber Energy Inc.
Start price
Target price
Perf. (%)
€151.00
04.10.21
04.10.21
€150.00
04.10.22
04.10.22
-62.91%
05.10.21
05.10.21
Could be worthwhile Investment >10% per year
Camber Energy Inc.
Start price
Target price
Perf. (%)
€133.00
29.09.21
29.09.21
€100.00
29.09.22
29.09.22
13.53%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Camber Energy Inc.
Start price
Target price
Perf. (%)
€76.33
14.11.19
14.11.19
€50.00
04.11.21
04.11.21
-64.63%
06.07.21
06.07.21
Could be worthwhile Investment >10% per year
Camber Energy Inc.
Start price
Target price
Perf. (%)
€106,250
15.02.19
15.02.19
€187,500
22.07.19
22.07.19
0.00%
22.07.19
22.07.19
Could be worthwhile Investment >10% per year